News & Updates
Filter by Specialty:
Liver transplant confers better long-term survival in select CRC patients
In the treatment of patients with nonresectable colorectal cancer (CRC) with liver metastases, liver transplantation may improve long-term survival outcomes especially when performed for those with favourable prognostic scoring, according to a study.
Liver transplant confers better long-term survival in select CRC patients
19 Sep 2023
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta
A recent study has found no amino acid substitutions associated with reduced sensitivity to bulevirtide (BLV) monotherapy, a hepatitis D/B virus (HDV/HBV) entry inhibitor, at baseline or week 24 in patients with virologic breakthrough after BLV treatment.
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta
13 Sep 2023
Noninvasive MRE accurately stages liver fibrosis in NAFLD
Magnetic resonance elastography demonstrates high accuracy in the noninvasive staging of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), reports a study.
Noninvasive MRE accurately stages liver fibrosis in NAFLD
13 Sep 2023
HILPDA induces development of NASH-driven HCC
Hepatic hypoxia-inducible lipid droplet associated protein (HILPDA) is predictive of survival in patients with nonalcoholic steatohepatitis (NASH)-driven hepatocellular carcinoma (HCC), according to a study.
HILPDA induces development of NASH-driven HCC
12 Aug 2023
Minimal monitoring feasible in HCV patients on SOF/VEL
Minimal monitoring is feasible in patients with active hepatitis C virus (HCV) infection treated with sofosbuvir/velpatasvir (SOF/VEL), with high rates of sustained virologic response (SVR) reported, including in patients with novel HCV subtypes, according to new data from the phase IV MINMON study presented at IDDF 2023.